Related to Life Technologies: A Look Back

• Reporting from J.P. Morgan Healthcare Conference
  Drug companies developing companion diagnostics is just one of the trends highlighted at the meeting.
  
• Synthetic Biology—The Devil Is in the Financial Details
  Oil companies’ significant investments have made biofuels the mainstay of R&D.
  
• Reporting from J.P. Morgan on Tool and Service Providers
  2011 is expected to be the year of recovery.
  
• Biotechs Nail Down Sequence of Elusive E. coli
  A new hybrid strain is responsible for the European outbreak that’s been all over the news.
  
• R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine
  Companies are focused on making these platforms smaller and easier to use.
  
• Sequencing Firms Set Up Centers to Advance Genomics Research and Instrument Sales
  Strategy provides a feedback loop to improve instrumentation and develop new applications.
  
• Sequencing in the Dark
  Analysis of Life Technologies’ Ion Torrent sequencing platform points to significance of photon-free technology.
  
• Enzo Sues Roche, Gen-Probe, and Life Technologies in Patent Infringement Case
  Patent under dispute expires in 2023, and defendants plan on fighting the lawsuit.
  
• Filings Postponed in Promega v. Life Tech as Parties Try to Settle
  Last month a jury awarded Promega $52 million in damages related to firm’s short tandem repeat technology.